Context Therapeutics posts results for terminated elacestrant-onapristone breast cancer trialJul 21Trial updateContext Therapeutics Inc.elacestrant
Results posted for onapristone-anastrozole trial in refractory endometrial cancerJul 17Trial updateanastrozoleContext Therapeutics Inc.
Sign inSign in